The EMBARC European Bronchiectasis Registry: protocol for an international observational study
Open Access
- 20 January 2016
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 2 (1)
Abstract
Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no approved therapies and few large-scale, representative epidemiological studies.The EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) registry is a prospective, pan-European observational study of patients with bronchiectasis. The inclusion criterion is a primary clinical diagnosis of bronchiectasis consisting of: 1) a clinical history consistent with bronchiectasis; and 2) computed tomography demonstrating bronchiectasis. Core exclusion criteria are: 1) bronchiectasis due to known cystic fibrosis; 2) age <18 years; and 3) patients who are unable or unwilling to provide informed consent.The study aims to enrol 1000 patients by April 2016 across at least 20 European countries, and 10 000 patients by March 2020. Patients will undergo a comprehensive baseline assessment and will be followed up annually for up to 5 years with the goal of providing high-quality longitudinal data on outcomes, treatment patterns and quality of life. Data from the registry will be available in the form of annual reports. and will be disseminated in conference presentations and peer-reviewed publications.The European Bronchiectasis Registry aims to make a major contribution to understanding the natural history of the disease, as well as guiding evidence-based decision making and facilitating large randomised controlled trials.Keywords
Funding Information
- COPD Foundation
- EU Innovative Medicines Initiative (iABC)
- Aradigm Corporation
- European Respiratory Society (CRC 2013-06)
- Bayer HealthCare
This publication has 44 references indexed in Scilit:
- Bronchiectasis-Associated Hospitalizations in Germany, 2005–2011: A Population-Based Study of Disease Burden and TrendsPLOS ONE, 2013
- Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasisMolecular Immunology, 2013
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- British Thoracic Society guideline for non-CF bronchiectasisThorax, 2010
- Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasisEuropean Respiratory Journal, 2009
- Mortality in bronchiectasis: a long-term study assessing the factors influencing survivalEuropean Respiratory Journal, 2009
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Bronchiectasis in secondary care: a comprehensive profile of a neglected diseaseEuropean Journal of Internal Medicine, 2003
- Bronchiectasis: an orphan disease with a poorly-understood prognosisEuropean Respiratory Journal, 1997
- CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.American Journal of Roentgenology, 1995